跳至主要内容
临床试验/EUCTR2015-002019-13-HU
EUCTR2015-002019-13-HU进行中(未招募)不适用

Reversal of deep pipecuronium neuromuscular block usingsugammadex: a randomized, double-blind, dosefindingstudy

niversity of Debrecen, Medical and Health Science Center, Department of Anaesthesiology and Intensive Therapy0 个研究点开始时间: 2015年8月19日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Patient aged 18-65 undergoing general surgery under combined
  • general anaesthesia with neuromuscular
  • 2. ASA (American Society of Anesthesiology) physical status score 1-3
  • 3. BMI (Body-Mass Index) 18,5-25
  • 4. duration of operation over 100 minutes
  • 5. need for intratracheal intubation
  • 6. supine position, at least one arm accessible
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 50
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. diseases influencing neuromuscular function (myopathies, significant
  • renal or hepatic insufficiency)
  • 2. drugs influencing neuromuscular function (magnesium,
  • aminoglycosides)
  • 3. gravidity, lactation
  • 4. urgent surgery
  • 5. chronic obstructive pulmonary disease
  • 6. glaucoma
  • 7. difficult airway management possible

研究者

发起方
niversity of Debrecen, Medical and Health Science Center, Department of Anaesthesiology and Intensive Therapy

相似试验

进行中(未招募)
不适用
Reversal of pipecuronium neuromuscular block using sugammadexThe effect of sugammadex dose on residual neuromuscular blockade willbe investigated, therefore patients suffering from various conditionsundergoing surgery in general anaesthesia with muscle relaxation willbe included in the study.
EUCTR2012-000259-14-HUniversity of Debrecen, Medical and Health Science Center, Department of Anaesthesiology and Intensive Therapy
尚未招募
不适用
Reversal of rocuronium induced neuromuscular block by sugammadex for electroconvulsive therapy; crossover designed dose response studyPsychiatric disease
JPRN-UMIN000007254Tokyo Women's Medical University Hospital20
进行中(未招募)
不适用
Reversal of neuromuscular block using sugammadex
EUCTR2011-001683-22-HUniversity of Debrecen, Medical and Health Science Center, Department of Anaesthesiology and Intensive Therapy
已完成
不适用
Rocuronium-induced neuromuscular block and reversibility with sugammadex at the corrugator supercilii and adductor pollicis musclesSurgical patients requiring general anesthesia
JPRN-UMIN000010240ihon University of Medicine Department of Anesthesiology40
进行中(未招募)
1 期
Recovery from deep neuromuscular blockade using different sugammadex doses in elderly patients undergoing laparoscopic robot-assisted prostatectomy: a prospective, randomized, double-blind clinical trial (RECIR)Deep neuromuscular block in patients undergoing RALP under general anaesthesiaMedDRA version: 21.1Level: PTClassification code 10057286Term: Neuromuscular blockade reversalSystem Organ Class: 10042613 - Surgical and medical procedures
EUCTR2020-004704-34-ITFONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE34